The candidate drug, TAK-875, was in the global phase-III development

The lectin was developed in a long-term NEDO project. Japan

The initial projects will focus on biomarker for amyotrophic lateral

The group of Professor Toshinori KINOSHITA overexpressed plasma membrane H+-ATPase

Clinical efficacy is not sufficiently higher as compared to control

After a 10 billion Yen supplementary budget was provided in

Among the 1063 types of receptors in mice, a few

Using inactivated viruses plated on a coated microarray plate, binding

The public partners are MAFFs NARO Institute of Floricultural Science,

The agreement covers development of therapeutic antibodies for cancer treatment.